MEDVIKTA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 43,189 | 31,037 | 15,026 | 13,893 | 34,600 | 35,782 | 23,641 | 8,082 |
| Profit before tax | -2 | - | - | - | - | - | - | - |
| Net profit | -2 | -1 | 0 | 1 | 2 | 5 | 8 | 6 |
| Equity | 31 | 2,896 | 2,896 | 2,896 | 2,896 | 2,896 | 2,896 | 2,896 |
| Liabilities | 22,848 | 20,186 | 18,417 | 14,713 | 18,305 | 25,585 | 25,585 | 15,371 |
| Non-current assets | 1,296 | 1,296 | 1,296 | 1,296 | 1,295 | 1,295 | 1,295 | 1,295 |
| Current assets | 21,583 | 18,920 | 17,151 | 19,259 | 17,045 | 24,295 | 24,295 | 14,087 |
| Total assets | 22,879 | 20,216 | 18,447 | 20,555 | 18,340 | 25,590 | 25,590 | 15,382 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,640 | 2,162 | 884 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +17.2% | -28.1% | -51.6% | -7.5% | +149.0% | +3.4% | -33.9% | -65.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -6.5% | 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.3% | 0.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.0% | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 737.0 | 7.0 | 6.4 | 5.1 | 6.3 | 8.8 | 8.8 | 5.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,396 | 10,346 | 5,009 | 4,631 | 11,533 | 11,927 | 7,880 | 2,694 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDVIKTA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-02-17 | 2022-03-13 | 0.01 |
MEDVIKTA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-04 | 2025-07-20 | 40.0 |
| 2025-06-06 | 2025-06-30 | 0.11 |
| 2025-06-04 | 2025-06-05 | 45.46 |
| 2025-05-07 | 2025-05-08 | 63.84 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDVIKTA, UAB (code 123493592) is a Private Limited Liability Company engaged in retail sale of footwear and leather goods. In 2025, the latest financial year, the company generated revenue of €8.1K and net profit of €6, resulting in a profit margin of 0.1%. Profitability remained positive but very limited in absolute terms. Revenue continued to weaken over the three-year period, falling from €35.8K in 2023 to €23.6K in 2024 and then to €8.1K in 2025, which represents a 65.8% year-on-year decline and a 77.4% drop versus 2023. Net profit stayed close to break-even throughout, at €5 in 2023, €8 in 2024 and €6 in 2025. At year-end 2025, total assets were €15.4K, equity stood at €2.9K and liabilities were €15.4K. The equity ratio was 18.8% and debt-to-equity 5.31. Asset turnover was 0.53x. Revenue per employee was €2.7K, while profit per employee was €2, indicating very limited operating scale.